Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Serum, plasma (heparin lithium, EDTA), urine and throat swab samples are kept in patients with novel coronavirus pneumonia and general fever patients, and the collection, processing and storage of the samples comply with the instructions; 2. Complete sample information, clear identification, traceable to the original record; 3. Inpatients of Zhongshan Hospital Affiliated to Fudan University and Geriatrics Center; 4. Informed consent for multi-omics study of Omicron COVID-19 infected patients should be signed; 5. Patients without underlying diseases are preferentially enrolled. Patients with common chronic diseases, such as hypertension, diabetes and cardiovascular diseases, can be enrolled.
Exclusion criteria
Exclusion criteria: 1. Samples with severe jaundice, turbidity, lipemia and hemolysis should be excluded; 2. Sample is insufficient, or contaminated, or sample information cannot be clearly identified; 3. The patient had a history of long-term drug use before admission, except for chronic diseases; 4. The patient has a history of malignancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| proteomics;metabolomics;whole genome sequencing; | — |
Countries
China